Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1555 entries
Sorted by: Best Match Show Resources per page
Genomic prediction of coronary heart disease.

European heart journal

Abraham G, Havulinna AS, Bhalala OG, Byars SG, De Livera AM, Yetukuri L, Tikkanen E, Perola M, Schunkert H, Sijbrands EJ, Palotie A, Samani NJ, Salomaa V, Ripatti S, Inouye M.
PMID: 27655226
Eur Heart J. 2016 Nov 14;37(43):3267-3278. doi: 10.1093/eurheartj/ehw450. Epub 2016 Sep 21.

AIMS: Genetics plays an important role in coronary heart disease (CHD) but the clinical utility of genomic risk scores (GRSs) relative to clinical risk scores, such as the Framingham Risk Score (FRS), is unclear. Our aim was to construct...

Cite
Abraham G, Havulinna AS, Bhalala OG, et al. Genomic prediction of coronary heart disease. Eur Heart J. 2016;37(43):3267-3278doi: 10.1093/eurheartj/ehw450.
Abraham, G., Havulinna, A. S., Bhalala, O. G., Byars, S. G., De Livera, A. M., Yetukuri, L., Tikkanen, E., Perola, M., Schunkert, H., Sijbrands, E. J., Palotie, A., Samani, N. J., Salomaa, V., Ripatti, S., & Inouye, M. (2016). Genomic prediction of coronary heart disease. European heart journal, 37(43), 3267-3278. https://doi.org/10.1093/eurheartj/ehw450
Abraham, Gad, et al. "Genomic prediction of coronary heart disease." European heart journal vol. 37,43 (2016): 3267-3278. doi: https://doi.org/10.1093/eurheartj/ehw450
Abraham G, Havulinna AS, Bhalala OG, Byars SG, De Livera AM, Yetukuri L, Tikkanen E, Perola M, Schunkert H, Sijbrands EJ, Palotie A, Samani NJ, Salomaa V, Ripatti S, Inouye M. Genomic prediction of coronary heart disease. Eur Heart J. 2016 Nov 14;37(43):3267-3278. doi: 10.1093/eurheartj/ehw450. Epub 2016 Sep 21. PMID: 27655226; PMCID: PMC5146693.
Copy Download .nbib Format: NLM
High risk for obstructive sleep apnea in patients with acute myocardial infarction.

Revista latino-americana de enfermagem

Andrechuk CR, Ceolim MF.
PMID: 26487128
Rev Lat Am Enfermagem. 2015 Sep-Oct;23(5):797-805. doi: 10.1590/0104-1169.0511.2617.

OBJECTIVES: to stratify the risk for obstructive sleep apnea in patients with acute myocardial infarction, treated at a public, tertiary, teaching hospital of the state of São Paulo, Brazil, and to identify related sociodemographic and clinical factors.METHOD: cross-sectional analytical...

Cite
Andrechuk CR, Ceolim MF. High risk for obstructive sleep apnea in patients with acute myocardial infarction. Rev Lat Am Enfermagem. 2015;23(5):797-805doi: 10.1590/0104-1169.0511.2617.
Andrechuk, C. R., & Ceolim, M. F. (2015). High risk for obstructive sleep apnea in patients with acute myocardial infarction. Revista latino-americana de enfermagem, 23(5), 797-805. https://doi.org/10.1590/0104-1169.0511.2617
Andrechuk, Carla Renata Silva, and Ceolim, Maria Filomena. "High risk for obstructive sleep apnea in patients with acute myocardial infarction." Revista latino-americana de enfermagem vol. 23,5 (2015): 797-805. doi: https://doi.org/10.1590/0104-1169.0511.2617
Andrechuk CR, Ceolim MF. High risk for obstructive sleep apnea in patients with acute myocardial infarction. Rev Lat Am Enfermagem. 2015 Sep-Oct;23(5):797-805. doi: 10.1590/0104-1169.0511.2617. Portuguese, Spanish. PMID: 26487128; PMCID: PMC4660400.
Copy Download .nbib Format: NLM
The challenge: landscape ecotoxicology and spatially explicit risk assessment.

Environmental toxicology and chemistry

Focks A.
PMID: 24838918
Environ Toxicol Chem. 2014 Jun;33(6):1193. doi: 10.1002/etc.2568.

No abstract available.

Cite
Focks A. The challenge: landscape ecotoxicology and spatially explicit risk assessment. Environ Toxicol Chem. 2014;33(6):1193doi: 10.1002/etc.2568.
Focks, A. (2014). The challenge: landscape ecotoxicology and spatially explicit risk assessment. Environmental toxicology and chemistry, 33(6), 1193. https://doi.org/10.1002/etc.2568
Focks, Andreas. "The challenge: landscape ecotoxicology and spatially explicit risk assessment." Environmental toxicology and chemistry vol. 33,6 (2014): 1193. doi: https://doi.org/10.1002/etc.2568
Focks A. The challenge: landscape ecotoxicology and spatially explicit risk assessment. Environ Toxicol Chem. 2014 Jun;33(6):1193. doi: 10.1002/etc.2568. PMID: 24838918.
Copy Download .nbib Format: NLM
In response: challenges and opportunities for landscape ecotoxicology and spatially explicit risk assessment--an industry perspective.

Environmental toxicology and chemistry

Price OR, Thorbek P.
PMID: 24838919
Environ Toxicol Chem. 2014 Jun;33(6):1194-6. doi: 10.1002/etc.2570.

No abstract available.

Cite
Price OR, Thorbek P. In response: challenges and opportunities for landscape ecotoxicology and spatially explicit risk assessment--an industry perspective. Environ Toxicol Chem. 2014;33(6):1194-6doi: 10.1002/etc.2570.
Price, O. R., & Thorbek, P. (2014). In response: challenges and opportunities for landscape ecotoxicology and spatially explicit risk assessment--an industry perspective. Environmental toxicology and chemistry, 33(6), 1194-6. https://doi.org/10.1002/etc.2570
Price, Oliver Richard, and Thorbek, Pernille. "In response: challenges and opportunities for landscape ecotoxicology and spatially explicit risk assessment--an industry perspective." Environmental toxicology and chemistry vol. 33,6 (2014): 1194-6. doi: https://doi.org/10.1002/etc.2570
Price OR, Thorbek P. In response: challenges and opportunities for landscape ecotoxicology and spatially explicit risk assessment--an industry perspective. Environ Toxicol Chem. 2014 Jun;33(6):1194-6. doi: 10.1002/etc.2570. PMID: 24838919.
Copy Download .nbib Format: NLM
The use of low-carbohydrate diet in type 2 diabetes - benefits and risks.

Annals of agricultural and environmental medicine : AAEM

Czyżewska-Majchrzak Ł, Grzelak T, Kramkowska M, Czyżewska K, Witmanowski H.
PMID: 24959782
Ann Agric Environ Med. 2014;21(2):320-6. doi: 10.5604/1232-1966.1108597.

The pharmacological treatment of type 2 diabetes is increasingly being supported by the recommendation of an appropriate diet. The purpose of this study is to identify the potential benefits and risks arising from the use of one of the...

Cite
Czyżewska-Majchrzak Ł, Grzelak T, Kramkowska M, et al. The use of low-carbohydrate diet in type 2 diabetes - benefits and risks. Ann Agric Environ Med. 2014;21(2):320-6doi: 10.5604/1232-1966.1108597.
Czyżewska-Majchrzak, �. �., Grzelak, T., Kramkowska, M., Czyżewska, K., & Witmanowski, H. (2014). The use of low-carbohydrate diet in type 2 diabetes - benefits and risks. Annals of agricultural and environmental medicine : AAEM, 21(2), 320-6. https://doi.org/10.5604/1232-1966.1108597
Czyżewska-Majchrzak, Łucja, et al. "The use of low-carbohydrate diet in type 2 diabetes - benefits and risks." Annals of agricultural and environmental medicine : AAEM vol. 21,2 (2014): 320-6. doi: https://doi.org/10.5604/1232-1966.1108597
Czyżewska-Majchrzak Ł, Grzelak T, Kramkowska M, Czyżewska K, Witmanowski H. The use of low-carbohydrate diet in type 2 diabetes - benefits and risks. Ann Agric Environ Med. 2014;21(2):320-6. doi: 10.5604/1232-1966.1108597. PMID: 24959782.
Copy Download .nbib Format: NLM
Integrated risk and recovery monitoring of ecosystem restorations on contaminated sites.

Integrated environmental assessment and management

Hooper MJ, Glomb SJ, Harper DD, Hoelzle TB, McIntosh LM, Mulligan DR.
PMID: 26465231
Integr Environ Assess Manag. 2016 Apr;12(2):284-95. doi: 10.1002/ieam.1731. Epub 2016 Feb 01.

Ecological restorations of contaminated sites balance the human and ecological risks of residual contamination with the benefits of ecological recovery and the return of lost ecological function and ecosystem services. Risk and recovery are interrelated dynamic conditions, changing as...

Cite
Hooper MJ, Glomb SJ, Harper DD, et al. Integrated risk and recovery monitoring of ecosystem restorations on contaminated sites. Integr Environ Assess Manag. 2016;12(2):284-95doi: 10.1002/ieam.1731.
Hooper, M. J., Glomb, S. J., Harper, D. D., Hoelzle, T. B., McIntosh, L. M., & Mulligan, D. R. (2016). Integrated risk and recovery monitoring of ecosystem restorations on contaminated sites. Integrated environmental assessment and management, 12(2), 284-95. https://doi.org/10.1002/ieam.1731
Hooper, Michael J, et al. "Integrated risk and recovery monitoring of ecosystem restorations on contaminated sites." Integrated environmental assessment and management vol. 12,2 (2016): 284-95. doi: https://doi.org/10.1002/ieam.1731
Hooper MJ, Glomb SJ, Harper DD, Hoelzle TB, McIntosh LM, Mulligan DR. Integrated risk and recovery monitoring of ecosystem restorations on contaminated sites. Integr Environ Assess Manag. 2016 Apr;12(2):284-95. doi: 10.1002/ieam.1731. Epub 2016 Feb 01. PMID: 26465231.
Copy Download .nbib Format: NLM
Invited commentary.

The Annals of thoracic surgery

Benussi S, Kieser T.
PMID: 24296180
Ann Thorac Surg. 2013 Dec;96(6):2060. doi: 10.1016/j.athoracsur.2013.08.036.

No abstract available.

Cite
Benussi S, Kieser T. Invited commentary. Ann Thorac Surg. 2013;96(6):2060doi: 10.1016/j.athoracsur.2013.08.036.
Benussi, S., & Kieser, T. (2013). Invited commentary. The Annals of thoracic surgery, 96(6), 2060. https://doi.org/10.1016/j.athoracsur.2013.08.036
Benussi, Stefano, and Kieser, Teresa. "Invited commentary." The Annals of thoracic surgery vol. 96,6 (2013): 2060. doi: https://doi.org/10.1016/j.athoracsur.2013.08.036
Benussi S, Kieser T. Invited commentary. Ann Thorac Surg. 2013 Dec;96(6):2060. doi: 10.1016/j.athoracsur.2013.08.036. PMID: 24296180.
Copy Download .nbib Format: NLM
Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome.

Heart (British Cardiac Society)

Labos C, Wang RH, Pilote L, Bogaty P, Brophy JM, Engert JC, Thanassoulis G.
PMID: 24842871
Heart. 2014 Oct;100(20):1620-4. doi: 10.1136/heartjnl-2013-305416.

OBJECTIVE: To examine the association between traditional risk factors (TRF) and a Genetic Risk Score (GRS) with age of first acute coronary syndrome (ACS). Early onset ACS may occur due to a high burden of TRFs or to genetic...

Cite
Labos C, Wang RH, Pilote L, et al. Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart. 2014;100(20):1620-4doi: 10.1136/heartjnl-2013-305416.
Labos, C., Wang, R. H., Pilote, L., Bogaty, P., Brophy, J. M., Engert, J. C., & Thanassoulis, G. (2014). Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart (British Cardiac Society), 100(20), 1620-4. https://doi.org/10.1136/heartjnl-2013-305416
Labos, Christopher, et al. "Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome." Heart (British Cardiac Society) vol. 100,20 (2014): 1620-4. doi: https://doi.org/10.1136/heartjnl-2013-305416
Labos C, Wang RH, Pilote L, Bogaty P, Brophy JM, Engert JC, Thanassoulis G. Traditional risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart. 2014 Oct;100(20):1620-4. doi: 10.1136/heartjnl-2013-305416. PMID: 24842871.
Copy Download .nbib Format: NLM
Clinical classification of plaque morphology in coronary disease.

Nature reviews. Cardiology

Otsuka F, Joner M, Prati F, Virmani R, Narula J.
PMID: 24776706
Nat Rev Cardiol. 2014 Jul;11(7):379-89. doi: 10.1038/nrcardio.2014.62. Epub 2014 Apr 29.

In published post-mortem pathological studies, more than two-thirds of acute coronary events are associated with the rupture of lipid-rich, voluminous, and outwardly remodelled plaques covered by attenuated and inflamed fibrous caps in the proximal part of coronary arteries. Superficial...

Cite
Otsuka F, Joner M, Prati F, et al. Clinical classification of plaque morphology in coronary disease. Nat Rev Cardiol. 2014;11(7):379-89doi: 10.1038/nrcardio.2014.62.
Otsuka, F., Joner, M., Prati, F., Virmani, R., & Narula, J. (2014). Clinical classification of plaque morphology in coronary disease. Nature reviews. Cardiology, 11(7), 379-89. https://doi.org/10.1038/nrcardio.2014.62
Otsuka, Fumiyuki, et al. "Clinical classification of plaque morphology in coronary disease." Nature reviews. Cardiology vol. 11,7 (2014): 379-89. doi: https://doi.org/10.1038/nrcardio.2014.62
Otsuka F, Joner M, Prati F, Virmani R, Narula J. Clinical classification of plaque morphology in coronary disease. Nat Rev Cardiol. 2014 Jul;11(7):379-89. doi: 10.1038/nrcardio.2014.62. Epub 2014 Apr 29. PMID: 24776706.
Copy Download .nbib Format: NLM
As Fracking Booms, Dearth Of Health Risk Data Remains.

Health affairs (Project Hope)

Tuller D.
PMID: 26056193
Health Aff (Millwood). 2015 Jun;34(6):903-6. doi: 10.1377/hlthaff.2015.0484.

No abstract available.

Cite
Tuller D. As Fracking Booms, Dearth Of Health Risk Data Remains. Health Aff (Millwood). 2015;34(6):903-6doi: 10.1377/hlthaff.2015.0484.
Tuller, D. (2015). As Fracking Booms, Dearth Of Health Risk Data Remains. Health affairs (Project Hope), 34(6), 903-6. https://doi.org/10.1377/hlthaff.2015.0484
Tuller, David. "As Fracking Booms, Dearth Of Health Risk Data Remains." Health affairs (Project Hope) vol. 34,6 (2015): 903-6. doi: https://doi.org/10.1377/hlthaff.2015.0484
Tuller D. As Fracking Booms, Dearth Of Health Risk Data Remains. Health Aff (Millwood). 2015 Jun;34(6):903-6. doi: 10.1377/hlthaff.2015.0484. PMID: 26056193.
Copy Download .nbib Format: NLM
Quality checklist to improve harms reporting. Is evidence-based medicine delivering on its promise?.

Oral diseases

Shahinas J.
PMID: 27169358
Oral Dis. 2017 Jan;23(1):3-4. doi: 10.1111/odi.12500. Epub 2016 Jun 29.

No abstract available.

Cite
Shahinas J. Quality checklist to improve harms reporting. Is evidence-based medicine delivering on its promise?. Oral Dis. 2016;23(1):3-4doi: 10.1111/odi.12500.
Shahinas, J. (2017). Quality checklist to improve harms reporting. Is evidence-based medicine delivering on its promise?. Oral diseases, 23(1), 3-4. https://doi.org/10.1111/odi.12500
Shahinas, J. "Quality checklist to improve harms reporting. Is evidence-based medicine delivering on its promise?." Oral diseases vol. 23,1 (2017): 3-4. doi: https://doi.org/10.1111/odi.12500
Shahinas J. Quality checklist to improve harms reporting. Is evidence-based medicine delivering on its promise?. Oral Dis. 2017 Jan;23(1):3-4. doi: 10.1111/odi.12500. Epub 2016 Jun 29. PMID: 27169358.
Copy Download .nbib Format: NLM
Microfluidic platforms for advanced risk assessments of nanomaterials.

Nanotoxicology

Mahto SK, Charwat V, Ertl P, Rothen-Rutishauser B, Rhee SW, Sznitman J.
PMID: 25051329
Nanotoxicology. 2015 May;9(3):381-95. doi: 10.3109/17435390.2014.940402. Epub 2014 Jul 22.

In the past few years, promising efforts to utilize microfabrication-based technologies have laid the foundation for developing advanced, and importantly more physiologically-realistic, microfluidic methods for risk assessment of engineered nanomaterials (ENMs). In the present review, we discuss the wave...

Cite
Mahto SK, Charwat V, Ertl P, et al. Microfluidic platforms for advanced risk assessments of nanomaterials. Nanotoxicology. 2014;9(3):381-95doi: 10.3109/17435390.2014.940402.
Mahto, S. K., Charwat, V., Ertl, P., Rothen-Rutishauser, B., Rhee, S. W., & Sznitman, J. (2015). Microfluidic platforms for advanced risk assessments of nanomaterials. Nanotoxicology, 9(3), 381-95. https://doi.org/10.3109/17435390.2014.940402
Mahto, Sanjeev Kumar, et al. "Microfluidic platforms for advanced risk assessments of nanomaterials." Nanotoxicology vol. 9,3 (2015): 381-95. doi: https://doi.org/10.3109/17435390.2014.940402
Mahto SK, Charwat V, Ertl P, Rothen-Rutishauser B, Rhee SW, Sznitman J. Microfluidic platforms for advanced risk assessments of nanomaterials. Nanotoxicology. 2015 May;9(3):381-95. doi: 10.3109/17435390.2014.940402. Epub 2014 Jul 22. PMID: 25051329.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1555 entries